Acumen Pharmaceuticals (NASDAQ:ABOS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Acumen Pharmaceuticals Stock (NASDAQ: ABOS) stock price, news, charts, stock research, profile.

Open	$2.30
Close	$2.37
Volume / Avg.	182.45K / 189.04K
Day Range	$2.26 - $2.38
52 Wk Range	2.08 - 5.09
Market Cap	$144.19M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	3.23%
Days to Cover	5.65

Recent News

Halozyme's ENHANZE Product Gets New Patent Grant in EU

Halozyme Therapeutics (NASDAQ: HALO) announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which is produced using the company's proprietary ENHANZE manufacturing methods.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.30
Close	$2.37
Volume / Avg.	182.45K / 189.04K
Day Range	$2.26 - $2.38
52 Wk Range	2.08 - 5.09
Market Cap	$144.19M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	3.23%
Days to Cover	5.65

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acumen Pharmaceuticals (ABOS) stock?

You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.

View our list of the best stock brokerages

Who are Acumen Pharmaceuticals (ABOS) competitors?

Other companies in Acumen Pharmaceuticals’s space includes: Innate Pharma (NASDAQ:IPHA), Invizyne Technologies (NASDAQ:IZTC), Skye Bioscience (NASDAQ:SKYE), Atossa Therapeutics (NASDAQ:ATOS) and PepGen (NASDAQ:PEPG).

What is the forecast, or price target, for Acumen Pharmaceuticals (ABOS) stock?

Acumen Pharmaceuticals has a consensus price target of $12.25.

What is the current price for Acumen Pharmaceuticals (ABOS)?

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $2.4 last updated November 22, 2024 at 6:21 PM EST.

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

There are no upcoming dividends for Acumen Pharmaceuticals.

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

Acumen Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.

Is Acumen Pharmaceuticals (ABOS) going to split?

There is no upcoming split for Acumen Pharmaceuticals.

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Acumen Pharmaceuticals

Acumen Pharmaceuticals (ABOS) Forecast